Underwriting

Stearns Lending Selects CoreLogic to Accelerate Borrower Income Calculation and Analysis

Thursday, January 21, 2021 - 3:00pm

CoreLogic (NYSE: CLGX), a leading global property information, analytics and data-enabled solutions provider, today announced that Stearns Lending, LLC, a leading independent mortgage bank, has successfully integrated CoreLogics income calculation and analysis solution.

Key Points: 
  • CoreLogic (NYSE: CLGX), a leading global property information, analytics and data-enabled solutions provider, today announced that Stearns Lending, LLC, a leading independent mortgage bank, has successfully integrated CoreLogics income calculation and analysis solution.
  • Our focus on improving the income calculation and analysis workflow had that objective in mind.
  • As for underwriters, it automates and standardizes the income analysis process, delivering faster and more consistent income calculations across underwriting teams.
  • CoreLogic is grateful to work with forward-thinking companies like Stearns, said Jay Kingsley, executive for Credit Solutions at CoreLogic.

Merus Announces Pricing of Public Offering of Common Shares

Thursday, January 21, 2021 - 1:40pm

UTRECHT, The Netherlands, and CAMBRIDGE, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, we and our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics and Triclonics), today announced the pricing of an underwritten public offering of 4,848,485 common shares at a public offering price of $24.75 per share.

Key Points: 
  • UTRECHT, The Netherlands, and CAMBRIDGE, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, we and our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics and Triclonics), today announced the pricing of an underwritten public offering of 4,848,485 common shares at a public offering price of $24.75 per share.
  • The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $120 million.
  • In addition, Merus granted the underwriters a 30-day option to purchase up to an additional 727,272 common shares at the public offering price, less the underwriting discounts and commissions.
  • All of the shares in the offering are to be sold by Merus.

Versus Systems Inc. Announces Closing of $11.0 Million Public Offering

Thursday, January 21, 2021 - 1:00pm

LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Versus Systems Inc. (Versus or the Company) (Nasdaq: VS) (CSE:VS) (FRANKFURT:BMVB) today announced that it closed its previously-announced public offering of 1,280,000 units.

Key Points: 
  • LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Versus Systems Inc. (Versus or the Company) (Nasdaq: VS) (CSE:VS) (FRANKFURT:BMVB) today announced that it closed its previously-announced public offering of 1,280,000 units.
  • Further, the underwriter has exercised in full its over-allotment option to purchase an additional 192,000 common shares, at the public offering price, less the underwriting discount.
  • The offering was priced at USD $7.50 per unit, for gross proceeds of USD $11,040,000, before deducting underwriting discounts and commissions and other offering expenses payable by Versus.
  • The Versus platform can be integrated into mobile, console, and PC games, as well as streaming media and mobile apps.

Southeastern Grocers Announces Launch of Initial Public Offering

Thursday, January 21, 2021 - 1:00pm

Southeastern Grocers, Inc. (Southeastern Grocers or the Company) today announced the launch of an initial public offering of 8,900,000 shares of its common stock to be sold by certain of its stockholders, at an anticipated initial public offering price between $14.00 and $16.00 per share, pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission (the SEC).

Key Points: 
  • Southeastern Grocers, Inc. (Southeastern Grocers or the Company) today announced the launch of an initial public offering of 8,900,000 shares of its common stock to be sold by certain of its stockholders, at an anticipated initial public offering price between $14.00 and $16.00 per share, pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission (the SEC).
  • BofA Securities and Goldman Sachs & Co. LLC are acting as joint lead book running managers and as representatives of the underwriters for the offering.
  • Deutsche Bank Securities Inc., BMO Capital Markets and Wells Fargo Securities are acting as book-running managers for the offering.
  • These forward-looking statements, including statements regarding the size, timing, expected price range and proceeds of the initial public offering, are based on the Companys current expectations and assumptions.

New CyberCube Scenarios Aid Lloyd’s Syndicates’ Cyber Planning

Thursday, January 21, 2021 - 12:30pm

These scenarios are used to report to Lloyd's on how their portfolio of business would be affected by major cyber events.

Key Points: 
  • These scenarios are used to report to Lloyd's on how their portfolio of business would be affected by major cyber events.
  • CyberCube has introduced the three scenarios for realistic cyber disasters as part of its Portfolio Manager product, which is used by risk carriers.
  • The three scenarios, which CyberCube designed in conjunction with Lloyds Underwriting team, Lloyds market practitioners and Guy Carpenter , are:
    The Lloyds Market Associations Cyber Risk Strategy Group has also been heavily involved in developing the scenarios over the past 15 months.
  • The three cyber scenarios, which will in future be included in Lloyds formal Realistic Disaster Scenario (RDS) framework, will play an important role in syndicates business planning processes.

CareDx Announces Pricing of Public Offering of Common Stock

Thursday, January 21, 2021 - 3:56am

The gross proceeds to CareDx from this offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $175,000,007.

Key Points: 
  • The gross proceeds to CareDx from this offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $175,000,007.
  • In addition, CareDx has granted the underwriters a 30 day option to purchase up to 288,461 additional shares of its common stock offered in the public offering on the same terms and conditions.
  • The offering is expected to close on or about January 25, 2021, subject to the satisfaction of customary closing conditions.
  • CareDx intends to use the net proceeds from this offering for working capital and general corporate purposes.

CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock

Thursday, January 21, 2021 - 2:50am

In addition, CytomX has granted the underwriters a 30-day option to purchase up to an additional 2,142,857 shares of its common stock at the public offering price, on the same terms and conditions.

Key Points: 
  • In addition, CytomX has granted the underwriters a 30-day option to purchase up to an additional 2,142,857 shares of its common stock at the public offering price, on the same terms and conditions.
  • CytomX expects to use the net proceeds from this offering to further develop its proprietary Probody therapeutics pipeline and research.
  • CytomX expects to use any remaining net proceeds from this offering for capital expenditures, working capital and other general corporate purposes.
  • J.P. Morgan Securities LLC, Cowen and Company, LLC and Piper Sandler are acting as joint bookrunning managers for the offering.

Dyne Therapeutics Announces Pricing of $168 Million Public Offering

Thursday, January 21, 2021 - 1:05am

WALTHAM, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $28.00 per share.

Key Points: 
  • WALTHAM, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $28.00 per share.
  • In addition, Dyne has granted the underwriters a 30-day option to purchase up to 900,000 additional shares of common stock at the public offering price, less the underwriting discount and commissions.
  • The gross proceeds of the offering, before deducting the underwriting discount and commissions and other offering expenses payable by Dyne, are expected to be approximately $168 million, excluding any exercise of the underwriters option to purchase additional shares.
  • Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.

Chimerix Announces Pricing of Public Offering of Common Stock

Thursday, January 21, 2021 - 1:02am

All of the shares to be sold in the offering are being sold by Chimerix.

Key Points: 
  • All of the shares to be sold in the offering are being sold by Chimerix.
  • The gross proceeds to Chimerix from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $100.0 million.
  • In addition, Chimerix has granted the underwriters a30-dayoption to purchase up to an additional 1,764,750 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • H.C. Wainwright & Co. is acting as lead manager for the offering and JonesTrading is acting as co-manager for the offering.

Dream Finders Homes, Inc. Announces Pricing of Initial Public Offering

Thursday, January 21, 2021 - 1:02am

JACKSONVILLE, Fla., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Dream Finders Homes, Inc. (NASDAQ: DFH) announced today the pricing of its initial public offering of 9,600,000 shares of Class A common stock at the initial public offering price of $13.00 per share.

Key Points: 
  • JACKSONVILLE, Fla., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Dream Finders Homes, Inc. (NASDAQ: DFH) announced today the pricing of its initial public offering of 9,600,000 shares of Class A common stock at the initial public offering price of $13.00 per share.
  • DFH expects to receive gross proceeds from the offering of approximately $124.8 million, before deducting underwriting discounts and estimated offering expenses, and excluding any exercise of the underwriters over-allotment option.
  • Builder Advisor Group, LLC and Zelman Partners LLC are joint lead managers for the offering.
  • This press release includes forward-looking statements regarding future events, including the expected closing of the offering and the expected use of net proceeds from the offering.